Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial P...

por Tu, Hai-Yan, Wu, Yi-Long
Publicado 2020

Genistein-3′-sulfonic acid dihydrate

por Zhang, Chang-Peng, Ni, Hao, Tu, Hai-Yan, Xie, Yong-Rong, Yang, Rui-Qing
Publicado 2009

Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases

por Li, Yang-Si, Zheng, Mei-Mei, Jiang, Ben-Yuan, Tu, Hai-Yan, Yang, Jin-Ji, Zhang, Xu-Chao, Wu, Yi-Long
Publicado 2020

Responses to crizotinib in a patient with c-ros oncogene 1, receptor tyrosine kinase-positive advanced lung adenocarcinoma: A case report

por ZHANG, NA, YANG, JIN-JI, ZHANG, XU-CHAO, XIE, ZHI, WANG, BIN-CHAO, TU, HAI-YAN, JIANG, BEN-YUAN, WU, YI-LONG
Publicado 2014

Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer

por Huang, Shu-Mei, Yang, Jin-Ji, Chen, Hua-Jun, Wu, Si-Pei, Bai, Xiao-Yan, Zhou, Qing, Tu, Hai-Yan, Wu, Yi-Long
Publicado 2017

Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report

por Tu, Hai-Yan, Li, Yang-Si, Yang, Jin-Ji, Chen, Hua-Jun, Jiang, Ben-Yuan, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Publicado 2021

Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer

por Yin, Zi-Jun, Tu, Hai-Yan, Fu, Ming, Zhong, Wen-Zhao, An, She-Juan, Yan, Hong-Hong, Chen, Hua-Jun, Lin, Hui-Ran, Wu, Yi-Long
Publicado 2018

Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases

por Wang, Zhen, Yu, Ruoying, Chen, Xiaoxi, Bao, Hua, Cao, Ran, Li, An-Na, Ou, Qiuxiang, Tu, Hai-Yan, Zhou, Qing, Wu, Xue, Lin, Zhi-Bo, Wu, Yi-Long
Publicado 2022

Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score

por Liu, Si-Yang Maggie, Sun, Hao, Zhou, Jia-Ying, Zhang, Jia-Tao, Yin, Kai, Chen, Zhi-Hong, Su, Jian, Zhang, Xu-Chao, Yang, Jin-Ji, Zhou, Qing, Tu, Hai-Yan, Wu, Yi-Long
Publicado 2021

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

por Zhou, Qing, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Xu, Chong-Rui, Su, Jian, Chen, Hua-Jun, Tu, Hai-Yan, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Publicado 2016

Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer p...

por Zhai, Hao-Ran, Yang, Xue-Ning, Nie, Qiang, Liao, Ri-Qiang, Dong, Song, Li, Wei, Jiang, Ben-Yuan, Yang, Jin-Ji, Zhou, Qing, Tu, Hai-Yan, Zhang, Xu-Chao, Wu, Yi-Long, Zhong, Wen-Zhao
Publicado 2017

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases

por Zheng, Mei-Mei, Li, Yang-Si, Tu, Hai-Yan, Sun, Hao, Yin, Kai, Jiang, Ben-Yuan, Yang, Jin-Ji, Zhang, Xu-Chao, Zhou, Qing, Xu, Chong-Rui, Wang, Zhen, Chen, Hua-Jun, Zhou, De-Xiang, Wu, Yi-Long
Publicado 2022

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

por Chen, Rui-Lian, Zhao, Jun, Zhang, Xu-Chao, Lou, Na-Na, Chen, Hua-Jun, Yang, Xue, Su, Jian, Xie, Zhi, Zhou, Qing, Tu, Hai-Yan, Zhong, Wen-Zhao, Yan, Hong-Hong, Guo, Wei-Bang, Wu, Yi-Long, Yang, Jin-Ji
Publicado 2018

Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients

por Wang, Zhen, Zhang, Xu-Chao, Feng, Wei-Neng, Zhang, Li, Liu, Xiao-Qing, Guo, Wei-Bang, Deng, Yan-Ming, Zou, Qing-Feng, Yang, Jin-Ji, Zhou, Qing, Wang, Bin-Chao, Chen, Hua-Jun, Tu, Hai-Yan, Yan, Hong-Hong, Wu, Yi-Long
Publicado 2023

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer

por Kang, Jin, Zhang, Xu-Chao, Chen, Hua-Jun, Zhong, Wen-Zhao, Xu, Yang, Su, Jian, Zhou, Qing, Tu, Hai-Yan, Wang, Zhen, Xu, Chong-Rui, Yang, Xue-Ning, Chen, Zhi-Hong, Wu, Xue, Zhang, Xian, Shao, Yang, Wu, Yi-Long, Yang, Jin-Ji
Publicado 2020

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

por Peng, Lun-Xi, Jie, Guang-Ling, Li, An-Na, Liu, Si-Yang, Sun, Hao, Zheng, Mei-Mei, Zhou, Jia-Ying, Zhang, Jia-Tao, Zhang, Xu-Chao, Zhou, Qing, Zhong, Wen-Zhao, Yang, Jin-Ji, Tu, Hai-Yan, Su, Jian, Yan, Hong-Hong, Wu, Yi-Long
Publicado 2021

Clinical outcomes of EGFR +/ METamp+ vs. EGFR +/ METamp‐ untreated patients with advanced non‐small cell lung cancer

por Peng, Kai‐Cheng, Su, Jun‐Wei, Xie, Zhi, Wang, Han‐Min, Fang, Mei‐Mei, Li, Wen‐Feng, Chen, Yu‐Qing, Guan, Xu‐Hui, Su, Jian, Yan, Hong‐Hong, Zhang, Xu‐Chao, Tu, Hai‐Yan, Zhou, Qing, Chen, Hua‐Jun, Wu, Yi‐Long, Yang, Jin‐Ji
Publicado 2022

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC

por Jie, Guang-Ling, Peng, Lun-Xi, Zheng, Mei-Mei, Sun, Hao, Wang, Song-Rong, Liu, Si-Yang Maggie, Yin, Kai, Chen, Zhi-Hong, Tian, Hong-Xia, Yang, Jin-Ji, Zhang, Xu-Chao, Tu, Hai-Yan, Zhou, Qing, Wong, Catherine C. L., Wu, Yi-Long
Publicado 2023

Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies

por Passaro, Antonio, de Marinis, Filippo, Tu, Hai-Yan, Laktionov, Konstantin K., Feng, Jifeng, Poltoratskiy, Artem, Zhao, Jun, Tan, Eng Huat, Gottfried, Maya, Lee, Victor, Kowalski, Dariusz, Yang, Cheng Ta, Srinivasa, BJ, Clementi, Laura, Jalikop, Tejaswini, Huang, Dennis Chin Lun, Cseh, Agnieszka, Park, Keunchil, Wu, Yi-Long
Publicado 2021

The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options

por Cui, Jiu-Wei, Zhou, Qing, Lu, Shun, Cheng, Ying, Wang, Jie, Bai, Ri-Lan, Li, Wen-Qian, Qian, Lei, Chen, Xiao-Yuan, Fan, Yun, Huang, Cheng, Liu, Xiao-Qing, Tu, Hai-Yan, Yang, Jin-Ji, Zhang, Li, Zhou, Jian-Ying, Zhong, Wen-Zhao, Wu, Yi-Long
Publicado 2021